Biomanufacturing

#ABPI #Biomanufacturing #Cancer research #Clinical trial #Diabetes #European Union #FDA #Fujifilm #Oncology #Priority Review #Rare diseases #RNA #UK

DDW Highlights: 17 February 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, researchers made a key discovery into cancer survival. Elsewhere, a global research effort… Read More

#Podcasts

#ABPI #Biomanufacturing #Cancer research #Clinical trial #Diabetes #European Union #FDA #Fujifilm #Oncology #Priority Review #Rare diseases #RNA #UK #United States

This week in Drug Discovery (9 – 13 February) 

News round-up for 9 – 13 February by Bruno Quinney, Content Team at DDW.  This week in DDW, researchers have made a key discovery into cancer survival. Elsewhere, a global research effort into kidney disease is underway.  The top stories:    Researchers identify RNA linked to cancer… Read More

#News

#Biomanufacturing #Fujifilm #NHS England #UK government

UK Chancellor hails FUJIFILM’s biomanufacturing expansion 

UK chancellor Rachel Reeves has hailed the expansion of FUJIFILM Biotechnologies facilities as “a vote of confidence in the UK”.  The Japanese company has expanded its facilities in the North East of England to support the biomanufacturing of innovative medicines and vaccines.  The company’s expanded… Read More

#News

#Biomanufacturing #Collaboration #Genetics / genomics #Synthetic biology #Synthetic DNA

Synthetic biology collaboration to develop plant genomics

A collaborative project led by the Max-Planck Institute of Molecular Plant Physiology (MPI-MP), Germany, aims to develop synthetic chloroplast genomes.  Enzymatic DNA synthesis company Camena Bioscience and whole genome writing specialists Constructive Bio are the latest companies to join the project.  Until now, constructing synthetic… Read More

#News

#Advanced Therapies #Biomanufacturing #Cell and gene therapy #Drug discovery #Manufacturing

New DDW Highlights podcast: 28 July 2025

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Following the recent news that the FDA rejected Ultragenyx Pharmaceutical’s gene therapy due to manufacturing concerns,… Read More

#News

#Advanced Therapies #Biomanufacturing #Cell and gene therapy #Drug discovery #Manufacturing

This week in drug discovery (21-25 July) 

News round-up for 21-25 July by DDW Senior Digital Content Editor Diana Turner. Following the recent news that the FDA rejected Ultragenyx Pharmaceutical’s gene therapy due to manufacturing concerns, manufacturing has dominated the headlines this week, particularly significant investment in facilities in the US, and new guidelines… Read More

#News

Female researcher in a laboratory
#Biologics #Biomanufacturing #Monoclonal antibodies #Phylloceuticals #Plant-based

US company hopes to transform access to advanced biologics

Phylloceuticals has announced the successful production of its first batch of a PD-1 inhibitor monoclonal antibody (mAb) just 12 weeks after initiating operations in its new laboratory space in Rapid City, South Dakota, US.   The company says the achievement marks a potential paradigm shift in how complex… Read More

#News

#Biomanufacturing #Biopharma #Collaboration #UK

UK business and academia partner on innovative biopharma research

Twenty-three new Prosperity Partnerships will tackle key industry challenges in areas from drug manufacturing and artificial intelligence to cybersecurity. The UKRI Engineering and Physical Sciences Research Council (EPSRC) is funding the partnerships with a £41 ($55.7) million investment, matched with a further £56 ($76) million from businesses and… Read More

#Business & Investment #News

A strip of 8 PCR tubes on the thermal cycler
#Biomanufacturing #Biotherapeutics #DNA #GMP #PCR #Webinar

Event today: Discover residual DNA quantitation using digital PCR

Join DDW and Thermo Fisher Scientific on 20 June, 11AM EDT/4PM BST, for an exclusive webinar, ‘Advancing biotherapy manufacturing: innovative strategies for residual DNA and viral titre quantitation using dPCR’. This free event will feature insight from Thermo Fisher Scientific’s Jonas Buege, Senior… Read More

#News

DNA helix
#Biomanufacturing #Biotherapeutics #DNA #GMP #PCR #Webinar

Webinar: Innovative solutions in biotherapeutic manufacturing

Join DDW and Thermo Fisher Scientific on 20 June, 11AM EDT/4PM BST, for an exclusive webinar, ‘Advancing biotherapy manufacturing: innovative strategies for residual DNA and viral titre quantitation using dPCR’. This free event will feature insight from Thermo Fisher Scientific’s Jonas Buege, Senior… Read More

#News

#Biomanufacturing #HUB Organoids #Molecular Devices #Organoids #UK #Wales

UK facility to manufacture organoids for drug discovery

A new facility has opened in Cardiff, UK designed to manufacture patient-derived organoids (PDOs) at scale for use in drug discovery and development. The multi-million-pound facility was custom-built by Molecular Devices to house its bioprocess workflow and bioreactor technology Mary Duseau, President of Molecular… Read More

#News

#Biomanufacturing #Biotherapeutics #DNA #GMP #PCR #Webinar

Webinar: Leveraging digital PCR assays in biotherapy manufacturing

Join DDW and Thermo Fisher Scientific on 20 June, 11AM EDT/4PM BST, for an exclusive webinar, ‘Advancing biotherapy manufacturing: innovative strategies for residual DNA and viral titre quantitation using dPCR’. This free event will feature insight from Thermo Fisher Scientific’s Jonas Buege, Senior… Read More

#News

PCR strip test tubes and micropipette in genetics laboratory
#Biomanufacturing #Biotherapeutics #DNA #GMP #PCR #Webinar

Webinar: Advancing biotherapy manufacturing

Join DDW and Thermo Fisher Scientific on 20 June, 11AM EDT/4PM BST, for an exclusive webinar, ‘Advancing biotherapy manufacturing: innovative strategies for residual DNA and viral titre quantitation using dPCR’. This free event will feature insight from Thermo Fisher Scientific’s Jonas Buege, Senior… Read More

#News

#Biomanufacturing #Biotherapeutics #Drug discovery #GMP #PCR

Innovative strategies for residual DNA and viral titre quantitation using dPCR

Leveraging digital PCR-based assays for the quantitation of residual host cell DNA or viral titres within a biotherapeutic manufacturing workflow offers significant value in ensuring product quality and safety. Digital PCR, or dPCR, is a highly sensitive and precise technique that enables the absolute quantification of nucleic acid targets. In… Read More

Webinar date:
Supported by Thermo Fisher Scientific
#Webinars

#Accelerated Bio #Biomanufacturing #Biotechnology #Cell engineering #Mekonos #Stem cells

New cell engineering partnership to accelerate biopharma innovation 

Mekonos, a company working towards cell engineering on a chip, has entered into a partnership agreement with Accelerated Bio to codevelop a new manufacturing cell line based on Accelerated Bio’s human Trophoblast Stem Cells (hTSCs) and Gene Engineered Multi-Sites (GEMS) technology.  Dr Anil Narasimha, Co-founder and Chief… Read More

#News

#Biomanufacturing #Biopharmaceuticals #Events #GMP #Microbiology #QA/QC #Webinar

Webinar: Environmental monitoring within biotherapeutic production

Join DDW for this free event, Implementing rapid microbial identification in biotherapy manufacturing: Enhancing quality control and regulatory compliance, which is supported by Thermo Fisher Scientific. The event will take place on 26 February 3 pm GMT / 4 pm CET / 10… Read More

#News